Advisory Board.

The Entourage Advisory Board.

The Entourage Advisory Board is our expert committee. Its members have decades of experience in science and business.

They have in-depth technical expertise, proven leadership skills, strategic know-how and established networks.

They help us to develop further and to offer our customers the best possible.

Entourage advisory board juergen freund

Jürgen Freund

Jürgen Freund first trained as an industrial clerk. He later earned his diploma in business administration (FH) at the Berlin School of Economics and Law.
Mr Freund has 30+ years of experience as a global procurement executive and has a broad range of know-how and experience in the pharmaceutical, biotechnology, diagnostics and medical technology industries. Mr. Freund has held positions including Global Head of Procurement at Merck Generics, London, UK, Head of Purchasing at Merck Serono in Geneva, Switzerland, Head of Procurement Region Europe and Head of Corporate Sourcing Segment Services at Merck in Darmstadt, Germany. Most recently, Mr Freund held the position of Chief Procurement Officer at B.Braun in Melsungen. Thanks to his many years in global management positions in procurement, he has a broad network both within and outside the industry.
Jürgen Freund supports Entourage as an advisory board member.

Entourage advisory board thomas nothegger

Dr. Thomas Nothegger

Dr Thomas Nothegger holds a PhD in Chemistry from the University of Innsbruck. He also completed a Master of Business Administration (MCI) at the Management Center in Innsbruck.
Dr Thomas Nothegger has over 20 years of experience in the pharmaceutical industry, mainly in the areas of Technical Operations (API and FDF), Product Development, Portfolio Management and Quality Management with a proven track record of successful turnarounds. He also successfully developed and implemented customer-centric strategies together with operational management. During his career, Dr Nothegger held global positions at Sandoz and Fresenius Kabi, gaining experience in Europe, North and South America and Asia. He is currently Head of Industrial Operations at Polpharma Group B.V..
Dr Thomas Nothegger supports Entourage as an advisory board member.

Entourage advisory Board hanns eberhard erle

Dr. Hanns-Eberhard Erle

Dr Hanns-Eberhard Erle holds a PhD in organic chemistry from the Johann Wolfgang Goethe University in Frankfurt am Main. Dr. Erle looks back on more than three decades of experience with global players in the pharmaceutical and biotechnology industries. The global product supply expert held executive and senior management positions at Merck KGaA, Aventis Pharma AG and Hoechst AG, among others, and was responsible for numerous plants in Germany and abroad. From 2007, he was Executive Vice President at Merck Serono, a member of the Executive Board, and as Head of Global Manufacturing & Supply he was responsible for production at 23 sites worldwide. Among other things, he built one of the world's largest biotech facilities in Vevey, Switzerland. Since 2014, Dr. Erle has been working as a freelance consultant.

Entourage advisory Board dr Andreas hartlep

Dr Andreas Hartlep

Dr Andreas Hartlep received diplomas in physics and medical physics. He also received his doctorate in physics from the German Cancer Research Centre and the Ruprecht Karls University in Heidelberg.
Dr Hartlep has more than 20 years of industry and relevant leadership experience from the medical technology sector, specifically in the areas of executive management, operations, R&D, M&A and venture capital. His main focus has been on restructuring companies at critical stages, executing international financings and M&A transactions, and growing and transforming young innovative companies into professional organisations, especially in the management of young companies and international strategic partnerships. During his career, Mr.. Dr Hartlep has received several entrepreneurial and scientific awards and 50 granted or pending patents.
Dr Andreas Hartlep supports Entourage as Advisory Board Medical Technologies and Devices.

Entourage advisory board markus boehringer

Dr. Markus Boehringer

Dr. Markus Boehringer studied veterinary medicine (LMU Munich) and completed his doctorate at the Institute of Human Medicine at the Technical University of Munich.
Dr Boehringer looks back on more than two decades in executive positions at renowned and globally active pharmaceutical and medical technology companies. For GlaxoSmithKline and Pfizer he held Director positions in Marketing, Sales and R&D. After his time in the pharmaceutical industry, he switched to medical technology in 2000. Initially he worked for a German subsidiary of the dental group Dentsply, before becoming Managing Director of Dentsply Australia/NZ in 2005. Later he took over the management board for Dentsply Asia. After his return to Europe, he was responsible for the "Endodontics" board division and the EMEA sales division from 2012. After the merger of Dentsply and Sirona, Dr Boehringer served as Senior Vice President EMEA. He was also a long-standing member of the Supervisory Board of DIO Korea and several DentsplySirona subsidiaries in Asia and Europe.

Entourage advisory board armin bolz

Prof. Dr. Armin Bolz

Prof. Dr. Armin Bolz studied physics and completed his doctorate and habilitation at the University of Erlangen on physical issues in implant development. His research results led to novel coating technologies, which he implemented as an entrepreneur in 1991. Today, these are still used worldwide in the production of stents and pacemakers. From 1995-1999 Mr. Bolz was employed as head of development at Biotronik. In 1999, he accepted a professorship for biomedical engineering at the Karlsruhe Institute of Technology (KIT). From 1999 to 2001 he was chairman of the German Society for Biomedical Engineering, and in 2001 also a member of the VDE board. In 2001, he founded CORSCIENCE GmbH & Co KG, which he managed very successfully until the end of 2016.

Advisory Board marita klafke

Marita Klafke

Marita Klafke holds a degree in business administration with a focus on healthcare and hospital management. In addition, she deepened her knowledge in business management, strategic management, financial management at Babson College, Massachusetts, USA and is a specialist nurse for anesthesia and intensive care medicine.
As a health care expert in international medical technology and hospital management, Ms. Klafke has more than two decades of experience in leadership, management, portfolio strategy and management. In addition, she has excellent intuition for customer and patient benefits, market developments and trends, and has extensive experience and expertise in setting up and expanding profit centers, business units and subsidiaries. Her other core competencies include general management, business development, sales and marketing. She rounds off her profile, which is characterized by internationality, with several years of work in the USA, including managing a US medical technology company and participating in executive programs at a US university. In 2022, the Interim Management Provider Working Group (AIMP) presented Ms. Klafke with the "Interim Manager of the Year" award.

Dr Sascha wettmarshausen

Dr Sascha Wettmarshausen

Dr Sascha Wettmarshausen received his diploma in chemistry from the University of Hannover. He completed his doctorate at the Federal Institute for Materials Research and Testing in Berlin. He completed his postdoc at Imperial College in London as a DFG fellow.
Dr Wettmarshausen is head of the Regulatory Affairs and QMS department in the German IVD Association (VDGH) and responsible for 8 committees and working groups. He is also vice-chairman of the Committee Regulatory Affairs and the working group Notified Bodiesin the European association Medtech Europe. He has been involved in guidance documents on the IVD Regulation and in its implementation. iin the European committees European committees involved in its implementation.He is in close contact with the German Notified Bodies, the Ministry of Health, authorities and other stakeholders. He was also involved in the entire legislative process of the IVDR and is in constant contact with the EU institutions. Furthermore, he sits on various advisory boards such as the advisory board of the German Medical Association and the NAMed at the German Institute for Standardisation (DIN).

Entourage advisory board johannes schmidt

Prof. Dr. Johannes Schmidt

Johannes Schmidt studied human medicine at the Friedrich-Alexander University of Erlangen-Nuremberg. During his training as a doctor of surgery, he completed his doctorate at the Institute of Physiology and Cardiology. Later, he additionally completed a Master of Health Business Administration at the University of Erlangen-Nuremberg.
Via positions as assistant physician and senior consultant, he was habilitated and received the authorisation to teach the subject "Surgery" with the appointment as private lecturer. After being elected head physician at the Lutherhaus Protestant Hospital in Essen (later Krupp Hospital Essen-Steele), he received the APL professorship for "Surgery". Prof. Dr. Schmidt was appointed Medical Director at the Lutherhaus Protestant Hospital in Essen and at the Academic Teaching Hospital of the Technical University of Munich in Landshut. Prof. Dr. Schmidt also received an honorary professorship from the University of Bucharest. Prof. Dr. Schmidt has also been active for many years in various supervisory board and executive board positions as well as an auditor.
Prof. Dr. Johannes Schmidt supports Entourage as an advisory board member.

Entourage advisory board pascal brenneisen

Pascal Brenneisen

Pascal Brenneisen studied law at the University of Basel and completed further training at INSEAD and Harvard Business School. As an executive, he held international positions in Operations, Marketing & Sales and General Management within the Novartis Group and, as CEO, is responsible for the Swiss business of the pharmaceutical giant. The manager gained widespread attention through his successful turn-around management of the Nyon plant, which secured over 700 jobs through long-term investments.
Pascal Brenneisen is Chairman of the Board of Directors of Entourage Pharma Consulting AG, based in Basel, Switzerland.

Entourage advisory board gerhard schaefer

Dr. Gerhard Schaefer

Dr. Gerhard Schaefer received his doctorate in organic chemistry from the University of Stuttgart in 1981. After his first professional positions in management positions in the areas of pharmaceutical development, quality control and quality assurance, he held management positions in business development at well-known companies such as Azupharma, Knoll, Stada, HEXAL and Sandoz. After being appointed to the Executive Board of HEXAL AG in 2003, Dr. Schaefer advanced to Managing Director of Sandoz International and Head of Global Product Development and Global Business Development following the acquisition of HEXAL AG by Novartis / Sandoz in 2005. In the period from 2005 to 2012, Dr. Schaefer was responsible for eleven global development sites. Since 2013, Dr. Gerhard Schaefer has been working as a freelance advisor and consultant for portfolio selection and product development at pharmaceutical companies in Germany, France and Poland.

Entourage advisory board guenther schoenrich

Prof. Dr. Günther Schönrich

Prof. Dr. med. Günther Schönrich studied medicine and philosophy at the Albert Ludwigs University in Freiburg and received his doctorate in medicine in 1985, specializing in cardiology. He completed his postdoctoral studies at the Institute of Immunology and Genetics of the German Cancer Research Center in Heidelberg. Mr. Schönrich has in-depth knowledge in the fields of microbiology, virology, infectious disease epidemiology, and immunology. Since 2006, Mr. Schönrich has been Deputy Director of the Institute of Virology (CCM) at Charité-Universitätsmedizin Berlin.

Advisory Board dr. Wilfried hauke

Dr. Wilfried Hauke

Dr Wilfried Hauke studied medicine at the Ludwig-Maximilians-Universität in Munich and received his doctorate in Frankfurt in 1991.
Dr. Hauke has been working in the pharmaceutical industry for over 30 years and was responsible for the clinical development of small molecules and biologics in various positions. During his professional career, Dr. Wilfried Hauke was able to take on tasks as a Qualified Person for Pharmacovigilance as a step-by-step plan representative for companies operating in Germany and set further focal points in risk-benefit analyses within the framework of due diligence processes, as well as rare disease / orphan drug development. Dr. Hauke has more than 35 years of industry experience and is a member of the Entourage Advisory Board for Medical and Clincial Research.